AMN

Over the past six months, AMN Healthcare Services, Inc. has seen its stock price increase by 85.09% from September 29, 2025, to September 28, 2026, with more recent gains of 2.03% in the past week and 9.27% in the past month. Key events include the Q2 CY2026 Earnings Report on August 6, 2026, where AMN Healthcare exceeded Wall Street's expectations for revenue ($673.2 million) and non-GAAP profit ($0.77 per share), leading to a 16.9% stock gain the day after earnings, alongside reporting $2.05 billion in H1 revenue and strong cash flow. A Q3 2026 Earnings Conference Call is scheduled for November 5, 2026. SEC filings noted the vesting of AMN Healthcare's CLO's RSUs on September 16, 2026, Morgan Stanley's disclosure of a 2.08 million-share beneficial stake on August 13, 2026, and a director trimming AMN holdings on June 17, 2026. Company news included the announcement of the Q3 2026 earnings call on October 7, 2026, AMN Healthcare joining the AONL Foundation's Corporate Advisory Council on August 17, 2026, and a report projecting persistent workforce strain across healthcare professions on August 12, 2026.